Epiretinal membrane. Puckering of macula, unspecified eye
Conditions
Interventions
Intervention 1: Intervention group: patients with idiopathic ERM who underwent pars plana vitrectomy and membrane peeling with intravitreal injection of triamcinolone acetonide (IVTA). Intervention 2:
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with idiopathic epiretinal membrane (ERM) Decreased vision(BCVA:20/400-20/40) or metamorphopsia Central foveal thickness more than 320 micron
Exclusion criteria
Exclusion criteria: Previous retinal surgery, retinal detachment, Age related macular degeneration, diabetic retinopathy, retinal vascular occlusion, uveitis vitreous hemorrhage, trauma ocular tumors, glaucoma optic atrophy, fibrotic epiretinal membrane, macular pathologies other than ERM, significant cataract corneal opacity incomplete chart records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Central subfield thickness. Timepoint: before operation and 1, 3, 6 and 12 months after operation. Method of measurement: macular OCT.;Best corrected visual acuity. Timepoint: before operation and 1, 3, 6 and 12 months after operation. Method of measurement: snellen chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Retinal sublayers. Timepoint: before operation and 1, 3, 6 and 12 months after operation. Method of measurement: optical coherence tomography.;Intraocular pressure. Timepoint: before operation and 1, 3, 6 and 12 months after operation. Method of measurement: Tonometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Namvar
Shiraz University of Medical Sciences
Outcome results
None listed